300 related articles for article (PubMed ID: 32232184)
21. Glomerular Endothelial Cell Stress and Cross-Talk With Podocytes in Early [corrected] Diabetic Kidney Disease.
Daehn IS
Front Med (Lausanne); 2018; 5():76. PubMed ID: 29629372
[TBL] [Abstract][Full Text] [Related]
22. Mechanism of progression of diabetic kidney disease mediated by podocyte mitochondrial injury.
Su J; Ye D; Gao C; Huang Q; Gui D
Mol Biol Rep; 2020 Oct; 47(10):8023-8035. PubMed ID: 32918716
[TBL] [Abstract][Full Text] [Related]
23. [Abnormality of renin-angiotensin system in podocyte dysfunction in diabetic kidney disease].
Shao DC; Lu LM
Sheng Li Ke Xue Jin Zhan; 2011 Aug; 42(4):246-50. PubMed ID: 22066414
[TBL] [Abstract][Full Text] [Related]
24. PFKP Activation Ameliorates Foot Process Fusion in Podocytes in Diabetic Kidney Disease.
Zhang Z; Liang W; Luo Q; Hu H; Yang K; Hu J; Chen Z; Zhu J; Feng J; Zhu Z; Chi Q; Ding G
Front Endocrinol (Lausanne); 2021; 12():797025. PubMed ID: 35095764
[TBL] [Abstract][Full Text] [Related]
25. Deletion of protein tyrosine phosphatase SHP-1 restores SUMOylation of podocin and reverses the progression of diabetic kidney disease.
Lizotte F; Rousseau M; Denhez B; Lévesque D; Guay A; Liu H; Moreau J; Higgins S; Sabbagh R; Susztak K; Boisvert FM; Côté AM; Geraldes P
Kidney Int; 2023 Oct; 104(4):787-802. PubMed ID: 37507049
[TBL] [Abstract][Full Text] [Related]
26. Urinary podocyte stress marker as a prognostic indicator for diabetic kidney disease.
Zeng L; Ng JK; Fung WW; Chan GC; Chow KM; Szeto CC
BMC Nephrol; 2024 Jan; 25(1):32. PubMed ID: 38267859
[TBL] [Abstract][Full Text] [Related]
27. Cellular crosstalk of glomerular endothelial cells and podocytes in diabetic kidney disease.
Jiang S; Luo M; Bai X; Nie P; Zhu Y; Cai H; Li B; Luo P
J Cell Commun Signal; 2022 Sep; 16(3):313-331. PubMed ID: 35041192
[TBL] [Abstract][Full Text] [Related]
28. Tripterygium glycoside protects diabetic kidney disease mouse serum-induced podocyte injury by upregulating autophagy and downregulating β-arrestin-1.
Zhan H; Jin J; Liang S; Zhao L; Gong J; He Q
Histol Histopathol; 2019 Aug; 34(8):943-952. PubMed ID: 30839094
[TBL] [Abstract][Full Text] [Related]
29. Macrophage inflammatory protein-1β as a novel therapeutic target for renal protection in diabetic kidney disease.
Chang TT; Li SY; Lin LY; Chen C; Chen JW
Biomed Pharmacother; 2023 May; 161():114450. PubMed ID: 36863097
[TBL] [Abstract][Full Text] [Related]
30. Integrating image analysis with single cell RNA-seq data to study podocyte-specific changes in diabetic kidney disease.
Govind D; Meamardoost S; Yacoub R; Gunawan R; Tomaszewski JE; Sarder P
Proc SPIE Int Soc Opt Eng; 2022; 12039():. PubMed ID: 37817877
[TBL] [Abstract][Full Text] [Related]
31. Placental Mesenchymal Stem Cells Alleviate Podocyte Injury in Diabetic Kidney Disease by Modulating Mitophagy via the SIRT1-PGC-1alpha-TFAM Pathway.
Han X; Wang J; Li R; Huang M; Yue G; Guan L; Deng Y; Cai W; Xu J
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36902127
[TBL] [Abstract][Full Text] [Related]
32. Crosstalk between tubular epithelial cells and glomerular endothelial cells in diabetic kidney disease.
Chen SJ; Lv LL; Liu BC; Tang RN
Cell Prolif; 2020 Mar; 53(3):e12763. PubMed ID: 31925859
[TBL] [Abstract][Full Text] [Related]
33. Sphingomyelinase-like phosphodiesterase 3b expression levels determine podocyte injury phenotypes in glomerular disease.
Yoo TH; Pedigo CE; Guzman J; Correa-Medina M; Wei C; Villarreal R; Mitrofanova A; Leclercq F; Faul C; Li J; Kretzler M; Nelson RG; Lehto M; Forsblom C; Groop PH; Reiser J; Burke GW; Fornoni A; Merscher S
J Am Soc Nephrol; 2015 Jan; 26(1):133-47. PubMed ID: 24925721
[TBL] [Abstract][Full Text] [Related]
34. p66Shc regulates podocyte autophagy in high glucose environment through the Notch-PTEN-PI3K/Akt/mTOR pathway.
Zheng D; Tao M; Liang X; Li Y; Jin J; He Q
Histol Histopathol; 2020 Apr; 35(4):405-415. PubMed ID: 31650524
[TBL] [Abstract][Full Text] [Related]
35. [The role of podocyte autophagy and endoplasmic reticulum stress in diabetic kidney disease].
Li R; Guo Z
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Feb; 34(2):221-224. PubMed ID: 35387735
[TBL] [Abstract][Full Text] [Related]
36. Placenta-derived mesenchymal stem cells protect against diabetic kidney disease by upregulating autophagy-mediated SIRT1/FOXO1 pathway.
Liu H; Wang J; Yue G; Xu J
Ren Fail; 2024 Dec; 46(1):2303396. PubMed ID: 38234193
[TBL] [Abstract][Full Text] [Related]
37. Lipid mediators of insulin signaling in diabetic kidney disease.
Mitrofanova A; Sosa MA; Fornoni A
Am J Physiol Renal Physiol; 2019 Nov; 317(5):F1241-F1252. PubMed ID: 31545927
[TBL] [Abstract][Full Text] [Related]
38. Glomerular Endothelial Mitochondrial Dysfunction Is Essential and Characteristic of Diabetic Kidney Disease Susceptibility.
Qi H; Casalena G; Shi S; Yu L; Ebefors K; Sun Y; Zhang W; D'Agati V; Schlondorff D; Haraldsson B; Böttinger E; Daehn I
Diabetes; 2017 Mar; 66(3):763-778. PubMed ID: 27899487
[TBL] [Abstract][Full Text] [Related]
39. Serum amyloid A and inflammation in diabetic kidney disease and podocytes.
Anderberg RJ; Meek RL; Hudkins KL; Cooney SK; Alpers CE; Leboeuf RC; Tuttle KR
Lab Invest; 2015 Mar; 95(3):250-62. PubMed ID: 25531567
[TBL] [Abstract][Full Text] [Related]
40. Identification and validation of immune-related biomarkers and potential regulators and therapeutic targets for diabetic kidney disease.
Chen S; Li B; Chen L; Jiang H
BMC Med Genomics; 2023 May; 16(1):90. PubMed ID: 37127580
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
